{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-051240","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2026-07-31T12:15:40+00:00","discovered_at":"2026-07-31T12:20:00.361729+00:00","generated_at":"2026-07-31T12:20:06.841365+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Iradimed Q2 revenue flat at $20.5M, EPS down; declares $0.20 dividend; reaffirms FY guidance","bullets":["Q2 revenue $20.5M (+0.5% YoY); GAAP EPS $0.41 (down from $0.45); non-GAAP EPS $0.46 (down from $0.49).","Declared quarterly cash dividend of $0.20 per share, payable Aug 28, 2026 to holders of record Aug 14.","Reaffirmed FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP EPS $2.09-2.24.","Launched next-gen 3870 MR IV pump; initial shipments met plan; domestic monitor unit bookings set record.","Q3 2026 guidance: revenue $23-24.5M, GAAP EPS $0.49-0.54, non-GAAP EPS $0.54-0.59."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-051240","json":"https://secwatch.observer/filing/0001628280-26-051240.json","markdown":"https://secwatch.observer/filing/0001628280-26-051240.md","text":"https://secwatch.observer/filing/0001628280-26-051240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000162828026051240/0001628280-26-051240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000162828026051240/irmd-20260731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-31T12:20:06.841365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}